Adobe Systems Inc vs Boston Scientific Corporation — how do they compare? Adobe Systems Inc trades at $261.49 (market cap $104.82B), while Boston Scientific Corporation trades at $50.96 (market cap $74.19B). The key difference: Adobe Systems Inc is the larger of the two by market cap, and Adobe Systems Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| ADBE | BSX | |
|---|---|---|
Market Cap | $104.82B | $74.19B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $367.46 | $108.14 |
52-Week Low | $193.41 | $42.63 |
Enterprise Value | $106.26B | $86.27B |
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $272.96, up 2.92% with strong technical momentum above key support at $270. The company demonstrates robust fundamentals with 2025 revenue of $23.77B and net income of $7.13B, maintaining exceptional profitability with 89.4% gross margins. Recent earnings beats and accelerating revenue growth contrast with mixed sentiment amid AI competition concerns and CEO transition uncertainty.
ADBE presents a compelling value proposition trading below analyst consensus targets with strong cash flow generation, though faces headwinds from AI disruption fears and sector volatility. The stock's current valuation at 15.62 P/E offers potential upside if execution continues, but requires monitoring of competitive threats and leadership stability.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →